selegiline has been researched along with Pneumonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, Y; Ip, MS; Liang, Y; Liu, KW; Mak, JC | 1 |
1 other study(ies) available for selegiline and Pneumonia
Article | Year |
---|---|
Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Bronchi; Cell Line; Cytoprotection; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Inflammation Mediators; Interleukin-8; Monoamine Oxidase; Monoamine Oxidase Inhibitors; NF-kappa B; Oxidative Stress; Pneumonia; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Selegiline; Signal Transduction; Smoke; Smoking | 2017 |